Literature DB >> 31801994

Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Yuichi Akasaki1, Mitsuru Ohishi2.   

Abstract

Drugs such as stimulants, sedatives, sleeping pills, and narcotics are associated with drug abuse and are therefore regulated by law. Physical dependence on these drugs is sometimes difficult to control despite an awareness of the problems they cause in daily life and the harm they can cause to the body. Drug dependence is a social problem worldwide, and the physical implications are serious. Many of these drugs cause cerebrovascular and cardiovascular diseases, which often require emergency medical treatment. Differential diagnosis is essential because of the likelihood of life-threatening events, especially among young people who exhibit cerebrovascular and cardiovascular diseases without any of the typical risk factors. Drugs of abuse, especially stimulants, induce a hyperadrenergic state that evokes vasoconstriction and tachycardia, as well as subsequent ischemic and hemorrhagic stroke, acute coronary syndrome, arrhythmias, and aortic dissection. Chronic drug abuse can also cause cardiac hypertrophy and left ventricular dysfunction. As a treatment for these conditions, sedative drugs can be effective but the use of vasodilators may also be required. There are concerns that the use of both alpha- and beta-adrenergic receptor blockers may cause tachycardia and increased blood pressure. Therefore, careful differential diagnosis and selection of therapeutic agents is required.

Entities:  

Keywords:  Blood pressure; Drug addiction; Stroke

Year:  2019        PMID: 31801994     DOI: 10.1038/s41440-019-0367-7

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  72 in total

Review 1.  Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.

Authors:  James McCord; Hani Jneid; Judd E Hollander; James A de Lemos; Bojan Cercek; Priscilla Hsue; W Brian Gibler; E Magnus Ohman; Barbara Drew; George Philippides; L Kristin Newby
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

2.  Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey.

Authors:  A I Qureshi; M F Suri; L R Guterman; L N Hopkins
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

3.  Neurovascular complications of cocaine use at a tertiary stroke center.

Authors:  Shahed Toossi; Christopher P Hess; Nancy K Hills; S Andrew Josephson
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-05-04       Impact factor: 2.136

4.  Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients.

Authors:  Arthur N Westover; Susan McBride; Robert W Haley
Journal:  Arch Gen Psychiatry       Date:  2007-04

Review 5.  Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.

Authors:  N D Volkow; J S Fowler; G J Wang
Journal:  J Psychopharmacol       Date:  1999-12       Impact factor: 4.153

Review 6.  [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.

Authors:  J S Fowler; N D Volkow; G J Wang; S J Gatley; J Logan
Journal:  Nucl Med Biol       Date:  2001-07       Impact factor: 2.408

7.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

8.  Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?

Authors:  D K Hatsukami; M W Fischman
Journal:  JAMA       Date:  1996-11-20       Impact factor: 56.272

Review 9.  Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.

Authors:  Katharine Phillips; Adriana Luk; Gursharan S Soor; Jonathan R Abraham; Shaun Leong; Jagdish Butany
Journal:  Am J Cardiovasc Drugs       Date:  2009       Impact factor: 3.571

10.  Diagnostic Yield of Universal Urine Toxicology Screening in an Unselected Cohort of Stroke Patients.

Authors:  Rizwan Kalani; Eric M Liotta; Shyam Prabhakaran
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.